UnknownNot Applicable

Viral Excretion Among COVID-19 Omicron Recurrence Patients

China35 participantsStarted 2022-07

Plain-language summary

The study analyzes the viral nucleic acid excretion and its influencing factors of SARS-COV-2 Omicron recurrence patients.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with nucleic acid detection N gene and ORF gene Ct value \< 40 after discharge from hospital * Being able to provide basic information, living habits, vaccination information, admission information Exclusion Criteria: * Single gene target positive * Patients with incomplete baseline data

What they're measuring

COVID-19 Omicron Recurrence

Timeframe: Six months

Trial details

NCT IDNCT05470426

SponsorRenJi Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07

Contact for this trial

Ya Yang, PhD

68383362 yangya@renji.com

View on ClinicalTrials.gov More COVID-19 Recurrence trials